Nixon Peabody Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.07M | Buy |
|
|||||
|
2025
Q2 | $762K | Buy |
|
|||||
|
2025
Q1 | $615K | Sell |
|
|||||
|
2024
Q4 | $540K | Buy |
|
|||||
|
2024
Q3 | $619K | Sell |
|
|||||
|
2024
Q2 | $802K | Hold |
|
|||||
|
2024
Q1 | $493K | Hold |
|
|||||
|
2023
Q4 | $632K | Buy |
|
|||||
|
2023
Q3 | $266K | Hold |
|
|||||
|
2023
Q2 | $285K | Hold |
|
|||||
|
2023
Q1 | $300K | Hold |
|
|||||
|
2022
Q4 | $356K | Hold |
|
|||||
|
2022
Q3 | $300K | Hold |
|
|||||
|
2022
Q2 | $219K | Hold |
|
|||||
|
2022
Q1 | $245K | Hold |
|
|||||
|
2021
Q4 | $254K | Hold |
|
|||||
|
2021
Q3 | $283K | Sell |
|
|||||
|
2021
Q2 | $339K | Hold |
|
|||||
|
2021
Q1 | $282K | Hold |
|
|||||
|
2020
Q4 | $260K | Hold |
|
|||||
|
2020
Q3 | $291K | Hold |
|
|||||
|
2020
Q2 | $296K | Hold |
|
|||||
|
2020
Q1 | $218K | Hold |
|
|||||
|
2019
Q4 | $230K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $238K | Hold |
|
|||||
|
2017
Q4 | $254K | Hold |
|
|||||
|
2017
Q3 | $235K | Buy |
|